It’s apparent that Archer have a clear path of development mapped out for the Biochip, even though it may not have been clearly defined with a timeline for SH.
I am comfortable with the fact that they have it and are methodically moving along the path.
The bulk of the market is waiting for the “big ticket” ANN at the final step of commercialisation. By then I envisage the SP will be well north of where it is now.
Ann: New Biochip gFET design sent to foundry partner in Spain, page-5
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.005(1.52%) |
Mkt cap ! $85.37M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 34.5¢ | 32.0¢ | $116.1K | 352.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5129 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 24040 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AXE (ASX) Chart |